Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 2
2009 3
2010 6
2011 8
2012 6
2013 12
2014 10
2015 4
2016 6
2017 5
2018 4
2019 2
2020 3
2021 3
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Vilanterol trifenatate for the treatment of COPD.
Malerba M, Radaeli A, Montuschi P, Morjaria JB. Malerba M, et al. Among authors: morjaria jb. Expert Rev Respir Med. 2016 Jul;10(7):719-31. doi: 10.1080/17476348.2016.1184976. Epub 2016 May 25. Expert Rev Respir Med. 2016. PMID: 27143334 Review.
Novel anti-cholinergics in COPD.
Prakash A, Babu KS, Morjaria JB. Prakash A, et al. Among authors: morjaria jb. Drug Discov Today. 2013 Nov;18(21-22):1117-26. doi: 10.1016/j.drudis.2013.07.005. Epub 2013 Jul 17. Drug Discov Today. 2013. PMID: 23872011 Review.
Emerging therapeutic strategies in COPD.
Babu KS, Morjaria JB. Babu KS, et al. Among authors: morjaria jb. Drug Discov Today. 2015 Mar;20(3):371-9. doi: 10.1016/j.drudis.2014.11.003. Epub 2014 Nov 13. Drug Discov Today. 2015. PMID: 25462534 Review.
E-cigarettes in patients with COPD: current perspectives.
Morjaria JB, Mondati E, Polosa R. Morjaria JB, et al. Int J Chron Obstruct Pulmon Dis. 2017 Nov 1;12:3203-3210. doi: 10.2147/COPD.S135323. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29138548 Free PMC article. Review.
Anti-IgE--emerging opportunities for Omalizumab.
Babu KS, Polosa R, Morjaria JB. Babu KS, et al. Among authors: morjaria jb. Expert Opin Biol Ther. 2013 May;13(5):765-77. doi: 10.1517/14712598.2013.782391. Epub 2013 Mar 22. Expert Opin Biol Ther. 2013. PMID: 23517576 Review.
Novel antitussive strategies.
Morjaria JB, Dickinson RS, Morice AH. Morjaria JB, et al. Drug Discov Today. 2013 Apr;18(7-8):380-8. doi: 10.1016/j.drudis.2012.11.004. Epub 2012 Nov 16. Drug Discov Today. 2013. PMID: 23159360 Review.
An evaluation of mepolizumab for the treatment of severe asthma.
Morjaria JB, Emma R, Fuochi V, Polosa R, Caruso M. Morjaria JB, et al. Expert Opin Biol Ther. 2019 Jun;19(6):491-500. doi: 10.1080/14712598.2019.1610382. Epub 2019 May 7. Expert Opin Biol Ther. 2019. PMID: 31009582 Review.
Preventing progression of allergic rhinitis to asthma.
Morjaria JB, Caruso M, Rosalia E, Russo C, Polosa R. Morjaria JB, et al. Curr Allergy Asthma Rep. 2014 Feb;14(2):412. doi: 10.1007/s11882-013-0412-6. Curr Allergy Asthma Rep. 2014. PMID: 24408536 Review.
71 results